With reference to the School of International Biodesign, consider the following:
1.SIB is a flagship Program of the Department of Biotechnology (DBT) aimed to develop innovative and affordable medical devices as per India’s unmet clinical needs.
2.It is implemented jointly at UNESCO MAB Programme and WWF India in collaboration with other International partners.
Which of the above is/are correct?
Explanation:
Statement 1: SIB, based in New Delhi, aims to cultivate a new generation of medical technology innovators in India.
Funded by the Indian Ministry of Science and Technology, the school is run by a consortium of Indian, Japanese and Australian universities.
Statement 2: It is implemented jointly at All India Institutes of Medical Sciences (AIIMS) and IIT Delhi in collaboration with International partners.
Biotech Consortium India Limited manages techno-legal activities of the Program. It serves as a valuable contribution to the Make in India campaign of the Government.